L
Linda S. Elting
Researcher at University of Texas MD Anderson Cancer Center
Publications - 203
Citations - 19126
Linda S. Elting is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 63, co-authored 199 publications receiving 17485 citations. Previous affiliations of Linda S. Elting include University of Texas at Austin & University of Texas System.
Papers
More filters
Journal ArticleDOI
Bacteremia Caused by Enterobacter: 15 Years of Experience in a Cancer Hospital
TL;DR: Enterobacter bacteremia was associated with shock in 24% of the patients and with disseminated intravascular coagulation in only 3%.
Journal ArticleDOI
Quality Gaps and Comparative Effectiveness in Lung Cancer Staging and Diagnosis
TL;DR: In this paper, the authors compared practice patterns and outcomes of diagnostic strategies in patients with lung cancer and found that guideline-consistent care with mediastinum sampling first resulted in fewer tests and complications.
Journal ArticleDOI
Time to Clinical Response: An Outcome of Antibiotic Therapy of Febrile Neutropenia With Implications for Quality and Cost of Care
Linda S. Elting,Edward B. Rubenstein,Kenneth V. I. Rolston,Scott B. Cantor,Charles G. Martin,Danna Kurtin,Saul Rodriguez,Tony Lam,Krishnakumari Kanesan,Gerald P. Bodey +9 more
TL;DR: An early discharge strategy based on the definition of the time point of clinical response may further reduce the cost of treating non-low-risk patients with febrile neutropenia.
Journal ArticleDOI
Coagulation Abnormalities Induced by β-Lactam Antibiotics in Cancer Patients
Victor Fainstein,G. P. Bodey,Kenneth B. McCredie,Michael J. Keating,Elihu Estey,Ricardo Bolivar,Linda S. Elting +6 more
TL;DR: Coagulation parameters must be routinely monitored when neutropenic cancer patients receive antibiotics known to cause coagulation abnormalities, and Alteration of the prothrombin time, with preservation of other parameters, was found in patients receiving antibiotic regimens containing semisynthetic penicillin and cefoxitin.
Journal ArticleDOI
Evaluating the impact of patient, tumor, and treatment characteristics on the development of jaw complications in patients treated for oral cancers: A SEER–Medicare analysis
Beth M. Beadle,Kai Ping Liao,Mark S. Chambers,Linda S. Elting,Thomas A. Buchholz,K. Kian Ang,Adam S. Garden,B. Ashleigh Guadagnolo +7 more
TL;DR: The impact of patient, tumor, and treatment characteristics on the development of jaw complications in patients treated with RT are identified.